Can erythrocytes behavior in microcirculation help the understanding the physiopathology and improve prevention and treatment for covid-19?
Abstract
Low plasma estrogens, vitamin D deficiency, obesity, diabetes, cardiovascular diseases, thromboembolism, and impaired microcirculation are linked to the severity of covid-19. Studies have suggested that these comorbidities also are related to erythrocyte factors linked to increased blood viscosity in microcirculation such as erythrocyte aggregation and erythrocyte deformability. Increased blood viscosity in microcirculation can lead to a decrease in oxygenation and nutrition of tissues. Therefore erythrocyte aggregation and erythrocyte deformability may be involved in covid-19 severity, leading to tissue hypoxia and a decrease of drug concentration in affected organs. If this relationship is demonstrated, erythrocytes factors can be used to monitor treatments for improve microcirculatory fluidity that may decrease covid-19 severity. Lifestyle improvement and treatments such as vitamin D and estrogens supplementation are some possible approaches to improve microcirculation and covid-19 prevention and treatment.
1Introduction
Covid-19 has caused a brutal toll of death and morbidity worldwide. By the beginning of December 2020, more than 70 million people were infected and more than 1.5 million deaths were documented worldwide [1]. This communication was done from a need to provide a possible alternative approach to the pathophysiology, prevention, and treatment of the disease, to try to improve morbidity and mortality by covid-19 and similar diseases.
Studies have suggested that low plasma estrogens [2, 3], vitamin D deficiency [4], obesity [5], diabetes [6], and cardiovascular diseases [7] are factors linked to the severity of covid-19. The most severe forms of covid-19 are often cursed with thromboembolic events [8–12] and impaired microcirculation [13–16]. Therefore factors related to all these conditions (low estrogens, vitamin D deficiency, obesity, diabetes, cardiovascular diseases, thromboembolic events, and impaired microcirculation) might be implicated in the pathophysiology of covid-19 complications.
2Blood viscosity in microcirculation
Firstly, is necessary the understanding blood viscosity in microcirculation. Blood is a non-Newtonian fluid, and the behavior of erythrocytes interferes with blood viscosity. The blood viscosity in microcirculation approaches plasma viscosity in vessels bigger than erythrocytes [17]. The importance of erythrocytes in blood viscosity increases as blood vessel diameter decrease and their influence is greater in vessels smaller than 300μm. Two erythrocyte factors can increase blood viscosity in microcirculation: The increased erythrocyte aggregation and the decreased erythrocyte deformability [18, 19]. There are also some compensatory factors, as the diameters of the vessels become smaller than 300μm. In these very small vessels, hematocrit decreases (Fåhræus effect) and there is a decrease of blood viscosity as the vessel diameter decrease (Fåhræus and Lindqvist effect), reducing the microvascular resistance associated with an accumulation of RBC in microcirculation, mainly in the bifurcations [20]. Therefore, low erythrocyte aggregation and high erythrocyte deformability are critical for blood flow in microcirculation. Impaired viscosity in microcirculation can impair the delivery of oxygen and nutrients to the tissues [21–24]. Therefore erythrocyte aggregation and erythrocyte deformability can interfere with oxygenation and nutrition of organs and tissues. If these erythrocytes behavior are altered in covid-19, it may be an explanation for the lesions caused by disease.
3Covid-19 comorbidities and erythrocyte behavior
Secondly, several comorbidities related to the severity of infection by the new coronavirus have been related to the behavior of erythrocytes in the microcirculation, namely erythrocyte aggregation and erythrocyte deformability, as listed below.
3.1Low estrogen
Studies have suggested that men are more susceptible and have a higher mortality rate by covid-19 than females, and the hormonal influence has been suggested as the reason for this difference [2, 25]. A study also suggests that postmenopausal women are more susceptible to covid-19 than premenopausal women [3]. Low estrogen also has been linked to erythrocytes behavior. When natural estrogen beta-estradiol or synthetic ethinyl estradiol are added to men’s blood, erythrocyte deformability increase accordingly with hormone’s concentration [26]. Transdermal beta-estradiol in hysterectomized women increases erythrocyte deformability and decreases erythrocyte aggregation [27]. Therefore, low estrogen is associated with hemorheological parameters linked to impairment in microcirculation which can explain why this factor is associated with severity and death for covid-19.
3.2Vitamin D deficiency
Low vitamin D is a risk factor for infection and hospitalization due to covid-19 [4, 28]. Low plasma levels of vitamin D have been associated with the worst prognosis of covid-19 [29]. Low vitamin D also has been linked to impaired hemorheology. In postmenopausal women, lower levels of 25-OH vitamin D in the blood are related to higher RBC aggregation and lower RBC deformability [30]. Therefore impaired hemorheology can explain why low vitamin D is associated with the worst prognosis of covid-19.
3.3Obesity
Most patients requiring mechanical ventilation for covid-19 are obese, and obese patients are more likely to die from covid-19 [5, 31]. Obesity also has been associated with hemorheological impairment. Patients with abdominal obesity show decreased erythrocyte deformability [32] while super obese patients show increased erythrocyte aggregation compared with morbid obese patients [33]. Patients with obesity and higher erythrocyte aggregation also have a higher risk of deep vein thrombosis [34]. Therefore, obesity is associated with both impairment of hemorheological parameters and severity of covid-19.
3.4Diabetes
Type 2 diabetes (T2D) has been associated with severity and mortality for covid-19 [6, 35]. T2D also has been associated with impaired hemorheology in microcirculation. The erythrocyte deformability is reduced in T2D patients compared with healthy controls and is even worse in T2D patients with complications as nephropathy or retinopathy [36]. Patients with T2D and non-alcoholic fatty liver diseases have higher whole blood viscosity and increased RBC aggregation [37]. Erythrocyte aggregation also is increased in poorly controlled T2D patients compared with non-diabetic controls [38]. Therefore, T2D is associated with a severity of covid-19 and impairment of hemorheological parameters in microcirculation.
3.5Cardiovascular diseases
Pre-existing cardiovascular diseases also have been linked with severity and mortality in patients with covid-19 [7]. Studies have also reported impairment of hemorheological parameters in cardiovascular diseases. Erythrocyte aggregation has been related to Lewis negative phenotype (individuals with increased atherosclerosis risk) along with inflammatory markers [39]. Patients with arterial hypertension have a decrease in erythrocyte deformability and an increase in erythrocyte aggregation [40, 41]. The severity of arterial hypertension is associated with increased erythrocyte aggregation and decreased erythrocyte deformability [42–44]. Erythrocyte deformability along with plasma viscosity and whole blood viscosity is associated with Framinghan cardiovascular risk score [45]. Erythrocyte aggregation and erythrocyte deformability also are linked to long term fatal and non-fatal events in transmural myocardial infarction survivors [46].
4Erythrocyte behavior and tissue hypoxia
As stated above, several comorbidities related to severity and death by covid-19 also are related to hemorheological parameters linked to microcirculatory impairment such as erythrocyte aggregation and erythrocyte deformability. Tissue hypoxia has been reported in death by covid-19 [47]. Hemorheological impairment can lead to a decrease to nutrition and oxygenation of the tissues, leading to hypoxia and a decrease of available nutrients [21–24]. Hypoxia and lack of nutrients in various tissues and organs can be a plausible explanation of the deleterious effect of the infection of the newel coronavirus. Some drugs can act in vitro against the new coronavirus but fail to treat the patient already infected [48]. A possible explanation can be that the drug cannot reach the place of the infection in the minimal inhibitory concentration due to microcirculatory impairment.
5New possible approaches for covid-19 prevention and treatment
Therefore, erythrocyte aggregation and deformability may be biomarkers for prevention and treatment approaches for covid-19, but this relationship should be confirmed. If a treatment improved these hemorheological parameters than microcirculation, tissue nutrition and tissue oxygenation should also be improved.
If covid-19 is related to hemorheological impairment, prevention of infection severity by the new coronavirus may be possible by improving hemorheological parameters while improving the comorbidities related to covid-19. Changes in lifestyle such as diet and physical activity have been reported to improve both red blood aggregation and deformability in diabetic subjects [49]. Erythrocyte aggregation also can be improved in obese subjects after diet, dependent on weight loss [50, 51]. Therefore, lifestyle improvement may enhance hemorheological parameters and its role in the prevention of severity of covid-19 should be investigated.
Although low vitamin D is related to the severity of covid-19 [4, 29] and impaired hemorheology [30], it has not yet been possible to verify whether vitamin D supplementation can prevent severe cases [52]. An approach that can be investigated is to determine which dose of vitamin D3 is necessary for improves hemorheology. If it is possible to determine the ideal dose or ideal blood concentration of vitamin D to improve blood rheology, this approach can become simple and inexpensive management for the prevention and treatment of covid-19.
This same approach can be used to test the ideal dose of female hormones to improve hemorheology in postmenopausal women since hormones such as estradiol have been shown to improve both erythrocyte aggregation and deformability [26, 27]. In the same way, currently approved treatments for covid-19 can be evaluated if they can improve these erythrocytes parameters.
6Conclusion
In conclusion, many studies are suggesting that comorbidities linked to severe covid-19 are also related to erythrocyte factors that increase blood viscosity in microcirculation, such as erythrocyte aggregation and erythrocyte deformability. The impaired microcirculation can be an explanation for the tissue lesion as seen in covid-19 severe cases. Changes in lifestyle, supplementation of hormones and vitamins, and drug treatments are some of the possible actions to improve hemorheology and the severity of the disease.
Conflict of interest
The authors have no conflict of interest to report.
References
[1] | Worldometer. Coronavirus Cases [Internet]. Worldometer. 2020 [cited 2020 Dec 11]. pp. 1–22. Available from: https://www.worldometers.info/coronavirus/? |
[2] | La Vignera S , Cannarella R , Condorelli RA , Torre F , Aversa A , Calogero AE . Sex-Specific SARS-CoV-2 Mortality: Among Hormone-Modulated ACE2 Expression, Risk of Venous Thromboembolism and Hypovitaminosis D. Int JMol Sci [Internet]. (2020) Apr 22 [cited 2020May 4];21: (8). Available from: http://www.ncbi.nlm.nih.gov/pubmed/32331343 |
[3] | Costeira R , Lee KA , Murray B , Christiansen C , Castillo-Fernandez J , Ni Lochlainn M , et al. Estrogen and COVID-19 symptoms: associations in women from the COVID Symptom Study. medRxiv [Internet]. 2020 Aug 19 [cited 2020 Dec 11];2020.07.30.20164921. Available from: https://doi.org/10.1101/2020.07.30.20164921 |
[4] | Merzon E , Tworowski D , Gorohovski A , Vinker S , Golan Cohen A , Green I , et al. Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study. FEBS J [Internet]. 2020 Jul 23 [cited 2020 Aug 17];febs.15495. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1111/febs.15495 |
[5] | Simonnet A , Chetboun M , Poissy J , Raverdy V , Noulette J , Duhamel A , et al. High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Requiring Invasive Mechanical Ventilation. Obesity. (2020) ;28: (7):1195–9. |
[6] | Guo W , Li M , Dong Y , Zhou H , Zhang Z , Tian C , et al. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev. (2020) ;36: (7). |
[7] | Nishiga M , Wang DW , Han Y , Lewis DB , Wu JC . COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol [Internet]. 2020 Jul 20 [cited 2020 Aug 17];1. Available from: /pmc/articles/PMC7370876/?report=abstract |
[8] | Llitjos J-F , Leclerc M , Chochois C , Monsallier J-M , Ramakers M , Auvray M , et al. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J Thromb Haemost [Internet]. 2020 Apr 22 [cited 2020 May 4]; Available from: http://www.ncbi.nlm.nih.gov/pubmed/32320517 |
[9] | Zhai Z , Li C , Chen Y , Gerotziafas G , Zhang Z , Wan J , et al. Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines. [cited 2020 May 4]; Available from: www.ssrn.com/index.cfm/en |
[10] | Jung EM , Stroszczynski C , Jung F . Contrast enhanced ultrasonography (CEUS) to detect abdominal microcirculatory disorders in severe cases of COVID-19 infection: First experience. Clin Hemorheol Microcirc [Internet]. (2020) [cited 2020 Dec 21];74: (4):353–61. Available from: https://pubmed.ncbi.nlm.nih.gov/32333581/ |
[11] | Jung EM , Stroszczynski C , Jung F . Contrast enhanced ultrasound (CEUS) to assess pleural pulmonal changes in severe COVID-19 infection: First results. Clin Hemorheol Microcirc [Internet]. (2020) [cited 2020 Dec 21];75: (1):19–26. Available from: https://pubmed.ncbi.nlm.nih.gov/32538830/ |
[12] | Peschel G , Jung EM , Fisser C , Putz FJ , Wertheimer T , Sinner B , et al. Interstitial lung opacities in patients with severe COVID-19 pneumonia by bedside high-resolution ultrasound in association to CO2 retention. Clin Hemorheol Microcirc [Internet]. 2020 Dec 1 [cited 2020 Dec 21];1-11. Available from: https://pubmed.ncbi.nlm.nih.gov/33285628/ |
[13] | Colantuoni A , Martini R , Caprari P , Ballestri M , Capecchi PL , Gnasso A , et al. COVID-19 Sepsis and Microcirculation Dysfunction [Internet]. Vol. 11, Frontiers in Physiology. Frontiers Media S.A.; 2020 [cited 2020 Aug 17]. pp. 747. Available from: /pmc/articles/PMC7333313/?report=abstract |
[14] | Pons S , Fodil S , Azoulay E , Zafrani L . The vascular endothelium: The cornerstone of organ dysfunction in severe SARS-CoV-2 infection [Internet]. Vol. 24, Critical Care. BioMed Central Ltd.; 2020 [cited 2020 Aug 17]. Available from: /pmc/articles/PMC7296907/?report=abstract |
[15] | Jung F , Krüger-Genge A , Franke RP , Hufert F , Küpper JH . COVID-19 and the endothelium. Clin Hemorheol Microcirc [Internet]. (2020) [cited 2020 Dec 21];75: (1):107–19. Available from: https://pubmed.ncbi.nlm.nih.gov/32568187/ |
[16] | Martini R . The compelling arguments for the need of microvascular investigation in COVID-19 critical patients. Clin Hemorheol Microcirc [Internet]. (2020) [cited 2020 Dec 21];75: (1):27–34. Available from: https://pubmed.ncbi.nlm.nih.gov/32568186/ |
[17] | Jung F , Rampling M . Role of blood viscosity in the microcirculation [Internet]. Vol. 64, Clinical Hemorheology and Microcirculation. IOS Press; 2016 [cited 2020 Dec 21]. pp. 251-4. Available from: https://pubmed.ncbi.nlm.nih.gov/28128756/ |
[18] | Baskurt OK , Ph D , Meiselman HJ , Sc D . Blood Rheology and Hemodynamics. (2003) ;1: (212):435–50. |
[19] | Chien S . Rheology in the microcirculation in normal and low flow states. Adv Shock Res [Internet]. (1982) [cited 2020 Dec 21];8: :71–80. Available from: https://pubmed.ncbi.nlm.nih.gov/7136948/ |
[20] | Chebbi R . Dynamics of blood flow: modeling of Fåhraeus and Fåhraeus–Lindqvist effects using a shear-induced red blood cell migration model. J Biol Phys. 2018;591-603. |
[21] | Chien S . Red Cell Deformability and its Relevance to Blood Flow. Annu Rev Physiol [Internet]. (1987) Mar 28 [cited 2020 Sep 4];49: (1):177–92. Available from: http://www.annualreviews.org/doi/10.1146/annurev.ph.49.030187.001141 |
[22] | Shevkoplyas SS , Yoshida T , Gifford SC , Bitensky MW . Direct measurement of the impact of impaired erythrocyte deformability on microvascular network perfusion in a microfluidic device. Lab Chip [Internet]. (2006) Jun 27 [cited 2020 Sep 4];6: (7):914–20. Available from: https://pubs.rsc.org/en/content/articlehtml/2006/lc/b601554a |
[23] | Baskurt OK , Meiselman HJ . Erythrocyte aggregation: Basic aspects and clinical importance. (2013) ;53: :23–37. |
[24] | Bishop JJ , Nance PR , Popel AS , Intaglietta M , Johnson PC . Relationship between erythrocyte aggregate size and flow rate in skeletal muscle venules. Am J Physiol Circ Physiol [Internet]. (2004) Jan [cited 2020 Sep 4];286: (1):H113–20. Available from: https://www.physiology.org/doi/10.1152/ajpheart.00587.2003 |
[25] | Williamson EJ , Walker AJ , Bhaskaran K , Bacon S , Bates C , Morton CE , et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature [Internet]. (2020) Aug 20 [cited 2020 Sep 4];584: (7821):430–6. Available from: https://pubmed.ncbi.nlm.nih.gov/32640463/ |
[26] | Farber PL , Freitas T , Saldanha C , Silva-Herdade AS . Beta-estradiol and ethinylestradiol enhance RBC deformability dependent on their blood concentration. Clin Hemorheol Microcirc [Internet]. (2018) [cited 2020 Apr 16];70: (3):339–45. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29710691 |
[27] | GonçalvesI, SaldanhaC, Martins e SilvaJ. β-estradiol effect on erythrocyte aggregation – A controlled in vitro study. Clin Hemorheol Microcirc. (2001) ;25: (3,4):127–34. |
[28] | Meltzer DO , Best TJ , Zhang H , Vokes T , Arora V , Solway J . Association of Vitamin D Status and Other Clinical Characteristics With COVID-19 Test Results. JAMA Netw open [Internet]. (2020) Sep 1 [cited 2020 Sep 6];3: (9):e2019722. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32880651 |
[29] | Munshi R , Hussein MH , Toraih EA , Elshazli RM , Jardak C , Sultana N , et al. Vitamin D insufficiency as a potential culprit in critical COVID-19 patients. J Med Virol [Internet]. 2020 Jul 27 [cited 2020 Sep 4]; Available from: https://pubmed.ncbi.nlm.nih.gov/32716073/ |
[30] | Farber PL , Dias A , Freitas T , Pinho AC , Viggiano D , Saldanha C , et al. Evaluation of Hemorheological Parameters as Biomarkers of Calcium Metabolism and Insulin Resistance in Postmenopausal Women. Clin Hemorheol Microcirc. 2020 Dec 29;Preprint(Preprint):1-16. |
[31] | Tartof SY , Qian L , Hong V , Wei R , Nadjafi RF , Fischer H , et al. Obesity and Mortality Among Patients Diagnosed With COVID-19: Results From an Integrated Health Care Organization. Ann Intern Med [Internet]. 2020 Aug 12 [cited 2020 Sep 6]; Available from: https://pubmed.ncbi.nlm.nih.gov/32783686/ |
[32] | Zeng NF , Mancuso JE , Zivkovic AM , Smilowitz JT , Ristenpart WD . Red blood cells from individuals with abdominal obesity or metabolic abnormalities exhibit less deformability upon entering a constriction. PLoS One. (2016) ;11: (6):1–12. |
[33] | Wiewiora M , Piecuch J , Glucka M , Slowinska-Lozynska L , Sosada K . The impacts of super obesity versus morbid obesity on red blood cell aggregation and deformability among patients qualified for bariatric surgery. Clin Hemorheol Microcirc. (2014) ;58: (4):543–50. |
[34] | Vayá A , Falcó C , Simó M , Ferrando F , Mira Y , Todoli J , et al. Influence of lipids and obesity on haemorheological parameters in patients with deep vein thrombosis. Thromb Haemost [Internet]. (2007) Sep [cited 2020 Sep 6];98: (3):621–6. Available from: https://pubmed.ncbi.nlm.nih.gov/17849051/ |
[35] | Kumar A , Arora A , Sharma P , Anikhindi SA , Bansal N , Singla V , et al. Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis. Diabetes Metab Syndr Clin Res Rev [Internet]. (2020) Jul 1 [cited 2020 Sep 6];14: (4):535–45. Available from: /pmc/articles/PMC7200339/?report=abstract |
[36] | Shin S , Ku YH , Ho JX , Kim YK , Suh JS , Singh M . Progressive impairment of erythrocyte deformability as indicator of microangiopathy in type 2 diabetes mellitus. Clin Hemorheol Microcirc. (2007) ;36: (3):253–61. |
[37] | Dong H , Lu F , Wang N , Zou X , Rao J . Type 2 diabetic patients with non-alcoholic fatty liver disease exhibit significant haemorheological abnormalities. (2011) ;5: (3):288–93. |
[38] | Bauersachs RM , Shaw SJ , Zeidler A , Meiselman HJ . Red blood cell aggregation and blood viscoelastically in poorly controlled type 2 diabetes mellitus. Clin Hemorheol. (1989) ;9: (6):935–52. |
[39] | Alexy T , Pais E , Wenby RB , Mack WJ , Hodis HN , Kono N , et al. Abnormal blood rheology and chronic low grade inflammation: Possible risk factors for accelerated atherosclerosis and coronary artery disease in Lewis negative subjects. Atherosclerosis [Internet]. (2015) Mar 1 [cited 2020 Dec 21];239: (1):248–51. Available from: https://pubmed.ncbi.nlm.nih.gov/25626016/ |
[40] | Guedes AF , Moreira C , Nogueira JB , Santos NC , Carvalho FA . Fibrinogen-erythrocyte binding and hemorheology measurements in the assessment of essential arterial hypertension patients. Nanoscale. (2019) ;11: (6):2757–66. |
[41] | Jung F , Spitzer S , Kiesewetter H , Feldmann M , Kotitschke G , Blum C , et al. Comparative investigation of the microcirculation in patients with hypertension and healthy adults. Klin Wochenschr [Internet]. (1986) Oct 1 [cited 2020 Dec 21];64: (19):956–61. Available from: https://pubmed.ncbi.nlm.nih.gov/3784447/ |
[42] | Fu G xiang , Ji M , Han L zhi , Xu C chan , Pan F feng , Hu T jun , et al. Erythrocyte rheological properties but not whole blood and plasma viscosity are associated with severity of hypertension in older people. Z Gerontol Geriatr [Internet]. (2017) Apr 1 [cited 2020 Sep 7];50: (3):233–8. Available from: https://link.springer.com/article/10.1007/s00391-016-1039-8 |
[43] | Konstantinova E , Ivanova L , Tolstaya T , Mironova E . Rheological properties of blood and parameters of platelets aggregation in arterial hypertension. Clin Hemorheol Microcirc. (2006) ;35: (1–2):135–8. |
[44] | Odashiro K , Saito K , Arita T , Maruyama T , Fujino T , Akashi K . Impaired deformability of circulating erythrocytes obtained from nondiabetic hypertensive patients: investigation by a nickel mesh filtration technique. Clin Hypertens [Internet]. (2015) Dec [cited 2020 Sep 7];21: (1). Available from: /pmc/articles/PMC4750801/?report=abstract |
[45] | Sandhagen B , Lind L . Whole blood viscosity and erythrocyte deformability are related to endothelium-dependent vasodilation and coronary risk in the elderly: The prospective investigation of the vasculature in Uppsala seniors (PIVUS) study. Clin Hemorheol Microcirc [Internet]. (2012) [cited 2020 Sep 7];50: (4):301–11. Available from: https://pubmed.ncbi.nlm.nih.gov/22240364/ |
[46] | SargentoL, SaldanhaC, MonteiroJ, PerdigãoC, Martins e SilvaJ. Long-term prognostic value of protein C activity, erythrocyte aggregation and membrane fluidity in transmural myocardial infarction. Thromb Haemost. (2005) ;94: (2):380–8. |
[47] | Wang K , Qiu Z , Liu J , Fan T , Liu C , Tian P , et al. Analysis of the clinical characteristics of 77 COVID-19 deaths. Sci Rep [Internet]. (2020) Dec 1 [cited 2020 Nov 15];10: (1). Available from: https://pubmed.ncbi.nlm.nih.gov/33009426/ |
[48] | Jomah S , Asdaq SMB , Al-Yamani MJ . Clinical efficacy of antivirals against novel coronavirus (COVID-19): A review. Vol. 13, Journal of Infection and Public Health. Elsevier Ltd; 2020. pp. 1187-95. |
[49] | Simmonds MJ , Minahan CL , Serre KR , Gass GC , Marshall-Gradisnik SM , Haseler LJ , et al. Preliminary findings in the heart rate variability and haemorheology response to varied frequency and duration of walking in women 65-74 yr with type 2 diabetes. Clin Hemorheol Microcirc. (2012) ;51: (2):87–99. |
[50] | Wiewiora M . The Effects of Weight Loss on Blood Rheology in Obese Patients. |
[51] | Hankey CR , Rumley A , Lowe GDO , Woodward M , Lean MEJ . Moderateweight reduction improves red cell aggregation and factor VII activity in overweight subjects. Int J Obes [Internet]. (1997) [cited 2020 Nov 6];21: (8):644–50. Available from: https://pubmed.ncbi.nlm.nih.gov/15481763/ |
[52] | Ali N . Role of vitamin D in preventing of COVID-19 infection, progression and severity. Vol. 13, Journal of Infection and Public Health. Elsevier Ltd; 2020. pp. 1373-80. |
